[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Bai et al., 2013 - Google Patents

Determination of thalidomide concentration in human plasma by liquid chromatography-tandem mass spectrometry

Bai et al., 2013

View HTML
Document ID
12048630388571062463
Author
Bai N
Cui X
Wang J
Sun C
Mei H
Liang B
Cai Y
Song X
Gu J
Wang R
Publication year
Publication venue
Experimental and Therapeutic Medicine

External Links

Snippet

A rapid, sensitive and specific analytical method based on high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) has been developed for the determination of thalidomide concentration in human plasma. The analyte and internal …
Continue reading at www.spandidos-publications.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/86—Signal analysis
    • G01N30/8665—Signal analysis for calibrating the measuring apparatus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/06—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins
    • A61K47/08—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycol [PEG]; Poloxamers; PEG/POE alkyl ethers

Similar Documents

Publication Publication Date Title
Li et al. Simultaneous quantitation of paracetamol, caffeine, pseudoephedrine, chlorpheniramine and cloperastine in human plasma by liquid chromatography–tandem mass spectrometry
Bai et al. Determination of thalidomide concentration in human plasma by liquid chromatography-tandem mass spectrometry
Zhou et al. Metabolite characterization of a novel sedative drug, remimazolam in human plasma and urine using ultra high-performance liquid chromatography coupled with synapt high-definition mass spectrometry
Yan et al. Comparative pharmacokinetics of berberine, palmatine and jatrorrhizine in rat plasma after oral administration of Rhizoma coptidis and Zuojinwan using liquid chromatography-tandem mass spectrometry
Maddela et al. Liquid chromatography–tandem mass spectrometric assay for eltrombopag in 50 μL of human plasma: A pharmacokinetic study
Iqbal et al. Determination of apremilast in rat plasma by UPLC–MS/MS in ESI-negative mode to avoid adduct ions formation
Hua et al. Simultaneous determination and pharmacokinetic study of gambogic acid and gambogenic acid in rat plasma after oral administration of Garcinia hanburyi extracts by LC‐MS/MS
Bu et al. Early rapid identification of in vivo rat metabolites of AN6414, a novel boron-containing PDE4 inhibitor by QTRAP LC/MS/MS to support drug discovery
Li et al. Pharmacokinetics and liver distribution study of unbound curdione and curcumol in rats by microdialysis coupled with rapid resolution liquid chromatography (RRLC) and tandem mass spectrometry
Wang et al. Characterization and quantification of histidine degradation in therapeutic protein formulations by size exclusion-hydrophilic interaction two dimensional-liquid chromatography with stable-isotope labeling mass spectrometry
Hashem et al. A rapid stability indicating LC-method for determination of praziquantel in presence of its pharmacopoeial impurities
Gabani et al. Simultaneous determination of colchicine and febuxostat in rat plasma: Application in a rat pharmacokinetic study
Liang et al. A rapid and sensitive LC–MS/MS method for the determination of vanillic acid in rat plasma with application to pharmacokinetic study
Rao et al. Development of a LC‐MS/MS method for simultaneous determination of metoprolol and its metabolites, α‐hydroxymetoprolol and O‐desmethylmetoprolol, in rat plasma: application to the herb–drug interaction study of metoprolol and breviscapine
Li et al. Simultaneous determination of ginkgolides A, B, C and bilobalide by LC‐MS/MS and its application to a pharmacokinetic study in rats
Liu et al. Simultaneous determination of bioactive components in essential oil of Xiang–Fu–Si–Wu Formula in Beagle dog plasma by UPLC–MS/MS and its application to pharmacokinetics
Dhiman et al. Determination of epacadostat, a novel IDO1 inhibitor in mouse plasma by LC–MS/MS and its application to a pharmacokinetic study in mice
Wang et al. Simultaneous determination by UPLC-MS/MS of seven bioactive compounds in rat plasma after oral administration of Ginkgo biloba tablets: application to a pharmacokinetic study
Shi et al. Pharmacokinetic study of calenduloside E and its active metabolite oleanolic acid in beagle dog using liquid chromatography–tandem mass spectrometry
Jiang et al. Simultaneous determination of 14-thienyl methylene matrine and matrine in rat plasma by high-performance liquid chromatography–tandem mass spectrometry and its application in a pharmacokinetic study
Dixit et al. Validated LC–MS/MS method for quantitation of a selective JAK1 inhibitor, filgotinib in rat plasma, and its application to a pharmacokinetic study in rats
Dai et al. Simultaneous determination of notoginsenoside R1 and ginsenoside Re in rat plasma by ultra high performance liquid chromatography with tandem mass spectrometry and its application to a pharmacokinetic study
Gupta et al. Selective and rapid determination of raltegravir in human plasma by liquid chromatography–tandem mass spectrometry in the negative ionization mode
Chen et al. Simultaneous determination of norisoboldine and its major metabolite in rat plasma by ultra‐performance liquid chromatography–mass spectrometry and its application in a pharmacokinetic study
Wang et al. PK study of octreotide based on LC–MS/MS combining protein precipitation and impurity extraction technique